Add to My Stocks
$5.15 $0 (0%) CLGN stock closing price Sep 19, 2018 (Closing)
Fiscal year is Jan - Dec2018 Q12017 Q42016 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow---
Net Increase (Decrease) in Assets Liabilities-0.22M-0.89M1.11M
Cash From (used in) Discontinued Operations---
Other Adjustments Net-1.45M1.05M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.21M-0.12M-0.13M
Acquisition Disposition of Subsidiaires---
Increase (Decrease) in Investments---
Other Cash Inflow (Outflow) from Investment Activities---
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-9.41M5.24M
Issuance (Repayment) of Debt Securities---
Increase (Decrease) in Bank & Other Borrowings---
Payment of Dividends & Other Cash Distributions---
Other Cash from (used by) Financing Activities-0.01M-0.07M-0.01M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash--0.01M-0.04M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year1.09M1.5M-
Cash & Equivalents at Year End3.94M5.13M1.07M
All figures in USD. M: Millions of USD, B: Billions of USD.

Key Financial Ratios For COLLPLANT HLDGS Cash Flow

Quarterly Cash Flow Statements For COLLPLANT HLDGS Peers

Bioasis Technologies cash flow, Egalet cash flow, ESSA Pharma cash flow, Eyegate Pharma cash flow